COMPANY

Skyhawk Therapeutics

HQ: Waltham, MA (US office) source · skyhawktx.com ↗ · New England

2 open jobs · last seen Oct 23, 2026 · 4 sources

We make orally-administered small molecule pills, taken daily, that bind to RNA and modify downstream protein production. From company website Source · Oct 12, 2026

Keywords: small molecule Huntington Disease Huntington's Disease SKY-0515

Location: Waltham, MA (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

2Open jobs 3Trials (company is sponsor)

Hiring

Title	Location (from posting)	Employer posted	First seen
Clinical Trial Associate	Waltham, MA	Oct 7, 2026	Oct 7, 2026
Clinical Trial Manager	Waltham, MA	Aug 27, 2026	Oct 9, 2026

See all 2 jobs

Timeline

Oct 5, 2026 Board tracked Radar started tracking this company’s job board (2 open jobs at last check). source ↗
Apr 10, 2026 Trial start Phase 2/Phase 3: An Extension of SKY-0515 in Participants With Huntington's Disease source ↗
Jan 6, 2026 Trial start Phase 2/Phase 3: Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease source ↗
May 27, 2025 Trial start Phase 2/Phase 3: Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease source ↗

Upcoming milestones

2027-05 (ESTIMATED) · Phase 2/Phase 3 · Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease · NCT06873334
2028-12 (ESTIMATED) · Phase 2/Phase 3 · Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease · NCT07378644
2029-12 (ESTIMATED) · Phase 2/Phase 3 · An Extension of SKY-0515 in Participants With Huntington's Disease · NCT07537075

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 2

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Clinical Trial Associate	Waltham, MA	Oct 7, 2026	Oct 7, 2026	Mid
Clinical Trial Manager	Waltham, MA	Aug 27, 2026	Oct 9, 2026	Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT07378644	Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease	Phase 2/Phase 3	Recruiting	Jan 6, 2026	2028-12 (estimated)
NCT07537075	An Extension of SKY-0515 in Participants With Huntington's Disease	Phase 2/Phase 3	Enrolling by invitation	Apr 10, 2026	2029-12 (estimated)
NCT06873334	Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease	Phase 2/Phase 3	Active, not recruiting	May 27, 2025	2027-05 (estimated)

Connect

See your connections at Skyhawk Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18